Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways
about
Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets?Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposureFluorescence-Based Strategies to Investigate the Structure and Dynamics of Aptamer-Ligand ComplexesLinking aptamer-ligand binding and expression platform folding in riboswitches: prospects for mechanistic modeling and designMolecular recognition and function of riboswitchesA decade of riboswitchesNovel Ligands for a Purine Riboswitch Discovered by RNA-Ligand DockingStructural principles of nucleoside selectivity in a 2′-deoxyguanosine riboswitchA Disconnect between High-Affinity Binding and Efficient Regulation by Antifolates and Purines in the Tetrahydrofolate RiboswitchSelective small-molecule inhibition of an RNA structural elementEmerging applications of riboswitches - from antibacterial targets to molecular toolsMetabolite recognition principles and molecular mechanisms underlying riboswitch functionStructure and function of preQ1 riboswitchesProspects for riboswitch discovery and analysisStructure-guided design of fluorescent S-adenosylmethionine analogs for a high-throughput screen to target SAM-I riboswitch RNAsPhylogenetic analysis and comparative genomics of purine riboswitch distribution in prokaryotesMining Functional Elements in Messenger RNAs: Overview, Challenges, and PerspectivesCartography of methicillin-resistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditionsNatural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formationThe Staphylococcus aureus RNome and its commitment to virulence.The purine riboswitch as a model system for exploring RNA biology and chemistryThe expanding view of RNA and DNA function.Identification of ligand analogues that control c-di-GMP riboswitches.Novel insights of structure-based modeling for RNA-targeted drug discovery.The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds.Constitutive regulatory activity of an evolutionarily excluded riboswitch variant.A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs.Term-seq reveals abundant ribo-regulation of antibiotics resistance in bacteria.Biophysical Approaches to Bacterial Gene Regulation by Riboswitches.Characterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections.Small molecule fluoride toxicity agonists.Rapid RNA-ligand interaction analysis through high-information content conformational and stability landscapes.De Novo Guanine Biosynthesis but Not the Riboswitch-Regulated Purine Salvage Pathway Is Required for Staphylococcus aureus Infection In VivoRNA-mediated regulation in pathogenic bacteria.Structure and mechanism of purine-binding riboswitches.How to cope with the quest for new antibiotics.Riboswitch structure in the ligand-free state.Current knowledge on regulatory RNAs and their machineries in Staphylococcus aureus.Structural insights into the interactions of xpt riboswitch with novel guanine analogues: a molecular dynamics simulation study.
P2860
Q21032531-CB3CFBC6-7967-43DF-9CE6-A738336C5A8DQ24596120-89CA3791-E208-4151-9B53-4BE75E186966Q26740493-F722823C-2104-45E2-93F8-986F23EFAA53Q26781454-7953D020-C1E9-4D95-BED5-AD6BCE64027BQ27000757-6DFCA938-3F17-4B95-B477-408F1D6186D6Q27000960-FE3EAA6F-0FDB-4981-8559-7F5819B42CCEQ27667324-D427CC5F-FDBB-4B64-9BFF-0FB0F8C8D10FQ27671766-17DEB381-E439-4B5A-B1A1-004499B13C5EQ27681170-E1BDBF17-D394-422C-9BD7-5C08985610F5Q27702218-489DA6D1-4739-4214-BAD1-8FDFA98D9F28Q28066512-24EB976E-1341-49A6-9BDE-3BC733566A96Q28109611-1087B5BB-E6A0-413F-BDF5-62B35635D26CQ28239535-848040A4-62B8-406D-B32F-64229B74FE80Q28654385-67649D39-7292-4FC3-85DB-FA9F790C7E5DQ28656519-96CB57B3-9B6E-4DA2-8D1A-54F23434837EQ28711956-93B4D74C-FD80-466C-A213-7D67E67DF8DFQ28729893-95D1788F-3039-4EB4-8AAC-89324E62C96FQ28752025-827AB1D6-00B8-4A46-9051-A3056DF97C4DQ30017477-2B9588EC-33E0-450D-A3A2-0803B29C7E54Q33851489-59D4A2B1-E25E-4D95-A166-748D89987899Q34105617-16A2BCA1-425F-4C37-8DF1-3E97BEC1EB77Q34228096-68AA3C26-5C08-4DCD-8D53-300D0DD9EE12Q34286207-EDFE0827-1F0A-4685-917E-CE44875E298AQ34402678-4FCF5BC5-750D-41CC-86EF-304AAC0DCF46Q34512304-394D1C06-0E4E-4CFC-B9D3-835B1990D386Q35144890-811FA161-195B-4003-8A80-4AEAF51854C6Q35332572-F83EEC30-0376-48E3-AB21-D53F2C80304FQ35350419-91FC4428-567D-4C1F-9775-BCC95572CD66Q36000911-E30983DF-6CFD-4D39-9C29-3F6CA1323EF0Q36021705-1519D2A6-5B79-432A-BD4A-C8BDD8E62B57Q36195087-BFC1F753-4FEF-48C9-9D54-3389BCF406C2Q36198639-9BBF7AA9-7ACE-4E6C-AD8D-A89FE6B03F3EQ36392455-52DDDB77-9C71-407F-BF46-558A4470BDCFQ37073234-2DC00011-EFC3-42F9-9A1A-526EDD59256CQ37122347-BA4B5F06-4665-41F3-ADF1-BAF186D05AA3Q37141554-98AA42A3-4DDE-421E-9706-B77BDA2F23BFQ37868070-D7245DF2-5585-47D9-8561-0B5A20CEB129Q37940436-F91354C7-FF45-4C04-A156-A4817B239D0AQ38006609-29C9BE11-5362-41B6-A6B1-0E0C5CA69A91Q38309863-AB266FE7-9BFB-418C-A7D5-8A908CA80F18
P2860
Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@ast
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@en
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@nl
type
label
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@ast
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@en
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@nl
prefLabel
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@ast
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@en
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@nl
P2093
P2860
P3181
P1433
P1476
Novel riboswitch ligand analog ...... ine-related metabolic pathways
@en
P2093
Daniel A Lafontaine
Eric Brouillette
Jérôme Mulhbacher
Marianne Allard
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1000865
P407
P577
2010-04-22T00:00:00Z